Empagliflozin, Linagliptin

Empagliflozin and Linagliptin is a combination medication used to treat type 2 diabetes in adults. It works by lowering blood sugar levels in two ways: first, by increasing the amount of sugar eliminated through urine, and second, by enhancing the body’s ability to produce insulin. This dual-action approach helps to maintain blood sugar levels within a healthy range, reducing the risk of complications associated with high blood sugar, such as heart disease, kidney disease, and nerve damage. This medication is typically prescribed when lifestyle changes and other oral diabetes medications have not been sufficient to control blood sugar levels. Empagliflozin and Linagliptin is not suitable for treating type 1 diabetes or diabetic ketoacidosis. Patients should consult with their healthcare provider before starting this medication to ensure it is appropriate for their individual needs and to discuss any potential side effects or interactions with other medications they may be taking.